Wegovy (semaglutide tablets) Pre-Order

Pre-Order – Wegovy tablets have been approved by the MHRA on 11 June 2026 and are expected to be available by the 7th of July. Order now to secure your place. Your prescription will be reviewed by one of our clinicians and your medication dispatched as soon as stock arrives. Wegovy is an MHRA licensed weight management treatment for adults in the UK. It contains semaglutide, the same active ingredient as Ozempic, made by Novo Nordisk, but at higher doses and licensed specifically for weight loss rather than type 2 diabetes. In clinical trials, patients on the 25mg maintenance dose lost an average of around 13.6% of their body weight over 64 weeks alongside a reduced calorie diet and increased physical activity. Wegovy is now available as a once-daily tablet offering the proven benefits of semaglutide without the need for injections. Is Wegovy right for you? Wegovy tablets are licensed for adults with a BMI of 30 or above, or 27 and above if you also have a weight related condition such as type 2 diabetes, raised blood pressure, high cholesterol, or obstructive sleep apnoea. It works alongside lifestyle changes rather than instead of them, so you'll need to commit to a reduced calorie diet and increased physical activity to get the best from it. Our clinicians check your eligibility as part of your consultation. How it works Semaglutide is a GLP-1 receptor agonist, which means it mimics one of the natural gut hormones your body releases after eating. By activating the GLP-1 receptor, it reduces your appetite, slows how quickly your stomach empties, and helps you feel full sooner and for longer. The result is fewer cravings and smaller portions feeling enough, which makes the lifestyle side of weight loss much more manageable. Your dosing schedule You'll start on a low dose so your body has time to adjust, and the dose increases gradually over the first few months. The standard schedule starts at 1.5mg once daily for the first 30 days, then increases to 4mg, then 9mg, and finally 25mg as your ongoing maintenance dose. Each step lasts around 30 days. Your clinician may slow this down if you're struggling with side effects, or keep you on a lower dose if it's working well for you. How to take the tablet The tablet should be taken once daily in the morning on an empty stomach, at least 30 minutes before your first food, drink, or other oral medication of the day. Take it with a small glass of water (no more than 120ml). Do not crush, chew, or split the tablet. What the clinical evidence shows Wegovy tablets have been studied in the OASIS clinical trial programme. Patients on the 25mg maintenance dose lost an average of around 13.6% of their body weight over 64 weeks. More than eight in ten participants lost at least 5% of their starting weight, and many also saw improvements in blood pressure, cholesterol, and blood sugar control. Your treatment with Rightangled We're a regulated UK pharmacy and prescribing service, which means every Wegovy prescription is reviewed by one of our GMC registered clinicians, not by an algorithm. Most assessments are reviewed the same day. Your medication is dispensed from our GPhC registered pharmacy and arrives in discreet packaging. Our clinical team is available throughout your treatment if anything comes up. What to expect from side effects The most common side effects are digestive: nausea, mild diarrhoea, constipation, and occasional vomiting. They're usually mild, tend to settle within a few weeks, and are most noticeable just after a dose increase. Eating smaller meals more often, easing off rich and fatty foods, and staying well hydrated makes a real difference for most patients. When Wegovy isn't suitable Wegovy isn't right for everyone. You shouldn't take it if you're pregnant, breastfeeding, or planning a pregnancy in the next two months, or if you've had a serious allergic reaction to semaglutide. It also isn't suitable if you have severe gastrointestinal disease, a history of pancreatitis, or if you're already on a similar medication such as Ozempic, Saxenda, or another GLP-1. Our clinicians review your full medical history during your consultation to make sure it's safe for you. This service is provided by Rightangled in partnership with Medetone pharmacy, regulated by the General Pharmaceutical Council and the Care Quality Commission. Wegovy® is a registered trademark of Novo Nordisk A/S.